Prostate Cancer Clinical Trial

Older Men’s Decision Making About Active Surveillance for Prostate Cancer – Aim 3: Decision Aid Cognitive and Usability Testing

Summary

This protocol describes development and user testing of an educational shared decision making intervention to help men with prostate cancer who are on active surveillance make decisions with their health care providers about if and when to de-escalate surveillance testing. The project is important because for many patients their cancer does not progress to the point of needed curative treatment or their health status changes such that they are no longer good candidates for treatment. For these men, de-escalating ongoing surveillance (e.g., fewer biopsies or imaging studies) is a reasonable option.

View Full Description

Full Description

Objectives:

The overall goal of this protocol is to develop and refine an educational tool for use by patients and health-care providers to help men with localized prostate cancer make informed decisions about discontinuation of active surveillance.

Conduct cognitive and initial usability and acceptability testing of a prototype decision aid with patients
Conduct cognitive and initial usability and acceptability testing of a prototype decision aid with care partners/caregivers
Conduct expert reviews of a prototype decision aid with clinicians

View Eligibility Criteria

Eligibility Criteria

Patients

Inclusion Criteria:

Males aged 65 or older
Diagnosis of localized prostate cancer
On active surveillance for 12 or more months
Fluent in English

Exclusion Criteria:

1. Receiving treatment for another cancer (primary or recurrence)

Caregivers

Inclusion Criteria:

Aged 18 or older
Fluent in English

Involved with the care of an eligible patient (i.e. partner, close friend, family member, companion)

Exclusion Criteria:

None

Clinicians

Inclusion Criteria:

Aged 18 or older
Fluent in English
Provides clinical care for patients with prostate cancer (e.g. medical oncologists, urologists, radiation oncologists, nurse practitioners, physician assistants)

Exclusion Criteria:

1. None

Study is for people with:

Prostate Cancer

Estimated Enrollment:

45

Study ID:

NCT05497024

Recruitment Status:

Recruiting

Sponsor:

M.D. Anderson Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

M D Anderson Cancer Center
Houston Texas, 77030, United States More Info
Lisa Lowenstein, MD
Contact
713-792-5807
[email protected]
Lisa Lowenstein, MD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

45

Study ID:

NCT05497024

Recruitment Status:

Recruiting

Sponsor:


M.D. Anderson Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.